Large strategics are optimistic about improving conditions in 2025 to support dealmaking and M&A; however, lessons learned in recent years will continue to drive a more disciplined approach among such leaders compared with levels of activity seen in the past.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?